Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SAR444656 for Hidradenitis Suppurativa
Recruiting0 awardsPhase 2
Pittsburgh, Pennsylvania
This trial will assess the effects of a new drug on adults with severe acne over a 24-week period. 14 visits will be required.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service